Search by Drug Name or NDC

    NDC 59651-0009-60 Ranolazine 500 mg/1 Details

    Ranolazine 500 mg/1

    Ranolazine is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is RANOLAZINE.

    Product Information

    NDC 59651-0009
    Product ID 59651-009_49873158-5c0a-41da-86a2-369ef6b0cbc8
    Associated GPIs
    GCN Sequence Number 060333
    GCN Sequence Number Description ranolazine TAB ER 12H 500 MG ORAL
    HIC3 A2C
    HIC3 Description ANTIANGINAL, ANTI-ISCHEMIC AGENTS,NON-HEMODYNAMIC
    GCN 26459
    HICL Sequence Number 033446
    HICL Sequence Number Description RANOLAZINE
    Brand/Generic Generic
    Proprietary Name Ranolazine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Ranolazine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 500
    Active Ingredient Units mg/1
    Substance Name RANOLAZINE
    Labeler Name Aurobindo Pharma Limited
    Pharmaceutical Class Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA209081
    Listing Certified Through 2024-12-31

    Package

    NDC 59651-0009-60 (59651000960)

    NDC Package Code 59651-009-60
    Billing NDC 59651000960
    Package 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-009-60)
    Marketing Start Date 2022-12-23
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.25719
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description RANOLAZINE ER 500 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis
    << 59651-0009-18 59651-0009-99 >>

    Contents